Dark
Light
System
Security
PROVECTUS BIOPHARMACEUTICALS I
PROVECTUS BIOPHARMACEUTICALS I. Institutional holdings reported to the SEC.

Institutional Holders (2014Q2)
Portfolio Summary: 27 Institutional holders with a total value of $1,087,621.
#
Manager Name
Shares
Value ($)
%
Options
Notes
1 GOLDMAN SACHS GROUP INC 304,389 262,000 24.09%
2 UBS AG 243,657 210,000 19.31%
3 Knoll Capital Management, LLC 200,000 172,000 15.81%
4 Virtu KCG Holdings LLC 88,026 76,000 6.99%
5 Commonwealth Equity Services, Inc 81,500 70,000 6.44%
6 LPL Financial LLC 45,200 39,000 3.59%
7 Creative Planning 31,400 27,000 2.48%
8 AMERICAN INTERNATIONAL GROUP, INC. 27,350 23,521 2.16%
9 PRINCETON CAPITAL MANAGEMENT LLC 25,000 22,000 2.02%
10 B. Riley Wealth Advisors, Inc. 25,000 21,500 1.98%
11 CITADEL ADVISORS LLC 21,748 19,000 1.75%
12 Private Advisor Group, LLC 21,575 19,000 1.75%
13 ACADEMY CAPITAL MANAGEMENT 20,000 17,000 1.56%
14 BROWN ADVISORY INC 20,000 17,000 1.56%
15 TRUST DEPARTMENT MB FINANCIAL BANK N A 20,000 17,000 1.56%
16 BANK OF MONTREAL /CAN/ 17,000 14,000 1.29%
17 DEUTSCHE BANK AG\ 14,500 12,000 1.10%
18 LADENBURG THALMANN FINANCIAL SERVICES INC. 14,200 12,000 1.10%
19 BANK OF AMERICA CORP /DE/ 10,530 9,000 0.83%
20 Janney Montgomery Scott LLC 10,000 8,600 0.79%
21 WELLS FARGO & COMPANY/MN 8,001 7,000 0.64%
22 MORGAN STANLEY 5,520 5,000 0.46%
23 GLENMEDE TRUST CO NA 5,000 4,000 0.37%
24 CITIGROUP INC 2,660 2,000 0.18%
25 Tortoise Investment Management, LLC 2,000 2,000 0.18%
26 Tower Research Capital LLC (TRC) 15 0 0.00%
27 Beacon Capital Management, Inc. 400 0 0.00%

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.